Evan K. Maxwell
Regeneron (United States)(US)Geisinger Health System(US)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Genomics and Rare Diseases, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Genetic Mapping and Diversity in Plants and Animals
Most-Cited Works
- → Computationally efficient whole-genome regression for quantitative and binary traits(2021)1,481 cited
- → Exome sequencing and analysis of 454,787 UK Biobank participants(2021)1,014 cited
- → Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis(2020)775 cited
- → Exome sequencing and characterization of 49,960 individuals in the UK Biobank(2020)622 cited
- → Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank(2021)423 cited
- → Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease(2022)176 cited
- → Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank(2022)172 cited
- → GlycReSoft: A Software Package for Automated Recognition of Glycans from LC/MS Data(2012)171 cited
- → Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes(2021)170 cited
- → Computationally efficient whole genome regression for quantitative and binary traits(2020)168 cited